mavorixafor will boost the stage or result of codeine by impacting hepatic enzyme CYP2D6 metabolism. Contraindicated. Mavorixafor (a robust CYP2D6 inhibitor) is contraindicated with medication which are hugely dependent on CYP2D6 for clearance. Optum Benefits is often a telehealth assistance